Hypercalcemia is the most common manifestation of hyperparathyroidism

Yukio Yuzawa, Y. Watanabe

Research output: Contribution to journalReview article

Abstract

Hypercalcemia accompanying with the elevation of parathyroid hormone (PTH) is critical for the differentiation of primary hyperparathyroidism (I HPT) from other diseases which show hypercalcemia. Recently, the reliable immunoassays for PTH especially for intact-PTH have been established and widely introduced in the clinical field. Marked development of cellular and molecular biology also contribute to the exploration of the mechanism of calcium/bone metabolism. The diagnosis of I HPT can be easily established in some patients by their typical clinical findings. Many of them, however, usually show asymptomatic hypercalcemia while some patients show normocalcemia. It is highly important to evaluate the parathyroid function precisely by several biochemical or hormonal parameters related to calcium metabolism for complete diagnosis and treatment.

Original languageEnglish
Pages (from-to)864-869
Number of pages6
JournalNippon rinsho. Japanese journal of clinical medicine
Volume53
Issue number4
Publication statusPublished - 01-04-1995
Externally publishedYes

Fingerprint

Hyperparathyroidism
Hypercalcemia
Parathyroid Hormone
Calcium
Primary Hyperparathyroidism
Immunoassay
Cell Biology
Molecular Biology
Bone and Bones
Therapeutics

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{fd12e7a7f13e4ac5986b08c629e76db0,
title = "Hypercalcemia is the most common manifestation of hyperparathyroidism",
abstract = "Hypercalcemia accompanying with the elevation of parathyroid hormone (PTH) is critical for the differentiation of primary hyperparathyroidism (I HPT) from other diseases which show hypercalcemia. Recently, the reliable immunoassays for PTH especially for intact-PTH have been established and widely introduced in the clinical field. Marked development of cellular and molecular biology also contribute to the exploration of the mechanism of calcium/bone metabolism. The diagnosis of I HPT can be easily established in some patients by their typical clinical findings. Many of them, however, usually show asymptomatic hypercalcemia while some patients show normocalcemia. It is highly important to evaluate the parathyroid function precisely by several biochemical or hormonal parameters related to calcium metabolism for complete diagnosis and treatment.",
author = "Yukio Yuzawa and Y. Watanabe",
year = "1995",
month = "4",
day = "1",
language = "English",
volume = "53",
pages = "864--869",
journal = "Nippon rinsho. Japanese journal of clinical medicine",
issn = "0047-1852",
publisher = "Nipponrinsho Co., Inc.",
number = "4",

}

Hypercalcemia is the most common manifestation of hyperparathyroidism. / Yuzawa, Yukio; Watanabe, Y.

In: Nippon rinsho. Japanese journal of clinical medicine, Vol. 53, No. 4, 01.04.1995, p. 864-869.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Hypercalcemia is the most common manifestation of hyperparathyroidism

AU - Yuzawa, Yukio

AU - Watanabe, Y.

PY - 1995/4/1

Y1 - 1995/4/1

N2 - Hypercalcemia accompanying with the elevation of parathyroid hormone (PTH) is critical for the differentiation of primary hyperparathyroidism (I HPT) from other diseases which show hypercalcemia. Recently, the reliable immunoassays for PTH especially for intact-PTH have been established and widely introduced in the clinical field. Marked development of cellular and molecular biology also contribute to the exploration of the mechanism of calcium/bone metabolism. The diagnosis of I HPT can be easily established in some patients by their typical clinical findings. Many of them, however, usually show asymptomatic hypercalcemia while some patients show normocalcemia. It is highly important to evaluate the parathyroid function precisely by several biochemical or hormonal parameters related to calcium metabolism for complete diagnosis and treatment.

AB - Hypercalcemia accompanying with the elevation of parathyroid hormone (PTH) is critical for the differentiation of primary hyperparathyroidism (I HPT) from other diseases which show hypercalcemia. Recently, the reliable immunoassays for PTH especially for intact-PTH have been established and widely introduced in the clinical field. Marked development of cellular and molecular biology also contribute to the exploration of the mechanism of calcium/bone metabolism. The diagnosis of I HPT can be easily established in some patients by their typical clinical findings. Many of them, however, usually show asymptomatic hypercalcemia while some patients show normocalcemia. It is highly important to evaluate the parathyroid function precisely by several biochemical or hormonal parameters related to calcium metabolism for complete diagnosis and treatment.

UR - http://www.scopus.com/inward/record.url?scp=0029282497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029282497&partnerID=8YFLogxK

M3 - Review article

VL - 53

SP - 864

EP - 869

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

SN - 0047-1852

IS - 4

ER -